Prospective cohort study identifying the predictors of TNF-α antagonist response to etanercept therapy in rheumatoid arthritis patients

Trial Profile

Prospective cohort study identifying the predictors of TNF-α antagonist response to etanercept therapy in rheumatoid arthritis patients

Completed
Phase of Trial: Phase IV

Latest Information Update: 10 Feb 2016

At a glance

  • Drugs Etanercept (Primary)
  • Indications Rheumatoid arthritis
  • Focus Therapeutic Use
  • Sponsors Pfizer
  • Most Recent Events

    • 10 Feb 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top